Visium Asset Management’s Edwards Lifesciences EW Stock Holding History

Visium Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-137,778	Closed	-$4.05M	–	396
2016 Q1	$4.05M	Sell	137,778 -1,042,026	-88%	-$28.8M	0.07%	297
2015 Q4	$31.1M	Sell	1,179,804 -232,848	-16%	-$6.05M	0.47%	40
2015 Q3	$33.5M	Sell	1,412,652 -913,686	-39%	-$22.1M	0.46%	44
2015 Q2	$55.2M	Buy	2,326,338 +2,229,432	+2,301%	+$50.3M	0.78%	22
2015 Q1	$2.3M	Buy	96,906 +69,588	+255%	+$1.56M	0.03%	401
2014 Q4	$580K	Sell	27,318 -3,282	-11%	-$65.9K	0.01%	671
2014 Q3	$521K	Sell	30,600 -7,356	-19%	-$116K	0.01%	770
2014 Q2	$543K	Sell	37,956 -2,364	-6%	-$32K	0.01%	696
2014 Q1	$499K	Sell	40,320 -44,712	-53%	-$516K	0.01%	586
2013 Q4	$932K	Sell	85,032 -1,713,918	-95%	-$19.3M	0.02%	461
2013 Q3	$20.9M	Buy	+1,798,950	New	+$21M	0.47%	47

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Visium Asset Management's EW Position: Q2 2016 in Review

Visium Asset Management sold out of Edwards Lifesciences (EW) in Q2 2016, closing a stake of 137,778 shares — an estimated $4.05M sold.

Visium Asset Management first reported a position in EW in Q3 2013 and held it in 11 quarters. The position peaked at $55.2M in Q2 2015. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

Visium Asset Management reported no remaining Edwards Lifesciences position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 137,778 Edwards Lifesciences shares in Q2 2016, an estimated $4.05M.
Visium Asset Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 11 quarters.
Visium Asset Management's Edwards Lifesciences position peaked at $55.2M in Q2 2015.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.